Despite a report that it may be considering settling thousands of US lawsuits relating to its former blockbuster diabetes drug Actos, Takeda Pharmaceutical has so far given no indications it intends to do so.
While a media report earlier this month suggested that Takeda has already offered to pay a total of $2.2bn to...